No Cover Image

Journal article 483 views 44 downloads

Willingness to receive a COVID-19 vaccine in people with multiple sclerosis - UK MS Register survey

Yun Huang, Jeff Rodgers, Rod Middleton Orcid Logo, Aravindhan Baheerathan, Katherine Tuite-Dalton, David Ford Orcid Logo, Richard Nicholas, Ms Register Research Group

Multiple sclerosis and related disorders, Volume: 55, Pages: 103175 - 103175

Swansea University Authors: Jeff Rodgers, Rod Middleton Orcid Logo, Katherine Tuite-Dalton, David Ford Orcid Logo

  • 57795.pdf

    PDF | Accepted Manuscript

    ©2021 All rights reserved. All article content, except where otherwise noted, is licensed under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND)

    Download (315.13KB)

DOI (Published version): 10.1016/j.msard.2021.103175

Abstract

Background & Methods: We conducted an online COVID-19 survey as the vaccines became available, utilising the UK MS Register, to understand people with multiple sclerosis (pwMS) views on COVID-19 vaccination and the subsequent vaccine uptake rates.Results & Conclusion: 94.4% of 3191 pwMS surv...

Full description

Published in: Multiple sclerosis and related disorders
Published: 2021
URI: https://cronfa.swan.ac.uk/Record/cronfa57795
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2021-09-07T10:45:41Z
last_indexed 2021-10-21T03:25:44Z
id cronfa57795
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2021-10-20T17:55:23.5473527</datestamp><bib-version>v2</bib-version><id>57795</id><entry>2021-09-07</entry><title>Willingness to receive a COVID-19 vaccine in people with multiple sclerosis - UK MS Register survey</title><swanseaauthors><author><sid>3ee27bde2acae56844ecdcbb563218ac</sid><firstname>Jeff</firstname><surname>Rodgers</surname><name>Jeff Rodgers</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>005518f819ef1a2a13fdf438529bdfcd</sid><ORCID>0000-0002-2130-4420</ORCID><firstname>Rod</firstname><surname>Middleton</surname><name>Rod Middleton</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>2e25da269f03da81184357bb0ef8623d</sid><firstname>Katherine</firstname><surname>Tuite-Dalton</surname><name>Katherine Tuite-Dalton</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>52fc0c473b0da1b7218d87f9fc68a3e6</sid><ORCID>0000-0001-6551-721X</ORCID><firstname>David</firstname><surname>Ford</surname><name>David Ford</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2021-09-07</date><deptcode>HDAT</deptcode><abstract>Background &amp; Methods: We conducted an online COVID-19 survey as the vaccines became available, utilising the UK MS Register, to understand people with multiple sclerosis (pwMS) views on COVID-19 vaccination and the subsequent vaccine uptake rates.Results &amp; Conclusion: 94.4% of 3191 pwMS surveyed indicated they would get a COVID-19 vaccine, while 5.6% would not. PwMS who have previously had an influenza vaccine, increasing age and the perception of having sufficient information about the vaccine were associated with increased likelihood of getting a vaccine. 51.7% of 3191 pwMS completed a follow-up survey indicating they received at least 1 dose of a COVID-19 vaccine. The proportion having had the vaccination based on their prior opinions was 53.2% in &#x2018;Yes&#x2019; group and 27.0% in &#x2018;No&#x2019; group, the latter reflecting a change based on their initial views. More information on COVID-19 vaccine safety in pwMS would be helpful for people to make informed decisions.</abstract><type>Journal Article</type><journal>Multiple sclerosis and related disorders</journal><volume>55</volume><journalNumber/><paginationStart>103175</paginationStart><paginationEnd>103175</paginationEnd><publisher/><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic/><keywords>Multiple Sclerosis, Covid-19, Vaccine, Vaccination, Uk Ms Register</keywords><publishedDay>1</publishedDay><publishedMonth>10</publishedMonth><publishedYear>2021</publishedYear><publishedDate>2021-10-01</publishedDate><doi>10.1016/j.msard.2021.103175</doi><url/><notes/><college>COLLEGE NANME</college><department>Health Data Science</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>HDAT</DepartmentCode><institution>Swansea University</institution><apcterm/><funders>Multiple Sclerosis Society Grant: 001</funders><lastEdited>2021-10-20T17:55:23.5473527</lastEdited><Created>2021-09-07T11:41:43.5583416</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Yun</firstname><surname>Huang</surname><order>1</order></author><author><firstname>Jeff</firstname><surname>Rodgers</surname><order>2</order></author><author><firstname>Rod</firstname><surname>Middleton</surname><orcid>0000-0002-2130-4420</orcid><order>3</order></author><author><firstname>Aravindhan</firstname><surname>Baheerathan</surname><order>4</order></author><author><firstname>Katherine</firstname><surname>Tuite-Dalton</surname><order>5</order></author><author><firstname>David</firstname><surname>Ford</surname><orcid>0000-0001-6551-721X</orcid><order>6</order></author><author><firstname>Richard</firstname><surname>Nicholas</surname><order>7</order></author><author><firstname>Ms Register Research</firstname><surname>Group</surname><order>8</order></author></authors><documents><document><filename>57795__20766__fc093eb8d3144f568f79301bd6f68919.pdf</filename><originalFilename>57795.pdf</originalFilename><uploaded>2021-09-07T12:25:21.2458924</uploaded><type>Output</type><contentLength>322695</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2022-07-27T00:00:00.0000000</embargoDate><documentNotes>&#xA9;2021 All rights reserved. All article content, except where otherwise noted, is licensed under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND)</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by-nc-nd/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling 2021-10-20T17:55:23.5473527 v2 57795 2021-09-07 Willingness to receive a COVID-19 vaccine in people with multiple sclerosis - UK MS Register survey 3ee27bde2acae56844ecdcbb563218ac Jeff Rodgers Jeff Rodgers true false 005518f819ef1a2a13fdf438529bdfcd 0000-0002-2130-4420 Rod Middleton Rod Middleton true false 2e25da269f03da81184357bb0ef8623d Katherine Tuite-Dalton Katherine Tuite-Dalton true false 52fc0c473b0da1b7218d87f9fc68a3e6 0000-0001-6551-721X David Ford David Ford true false 2021-09-07 HDAT Background & Methods: We conducted an online COVID-19 survey as the vaccines became available, utilising the UK MS Register, to understand people with multiple sclerosis (pwMS) views on COVID-19 vaccination and the subsequent vaccine uptake rates.Results & Conclusion: 94.4% of 3191 pwMS surveyed indicated they would get a COVID-19 vaccine, while 5.6% would not. PwMS who have previously had an influenza vaccine, increasing age and the perception of having sufficient information about the vaccine were associated with increased likelihood of getting a vaccine. 51.7% of 3191 pwMS completed a follow-up survey indicating they received at least 1 dose of a COVID-19 vaccine. The proportion having had the vaccination based on their prior opinions was 53.2% in ‘Yes’ group and 27.0% in ‘No’ group, the latter reflecting a change based on their initial views. More information on COVID-19 vaccine safety in pwMS would be helpful for people to make informed decisions. Journal Article Multiple sclerosis and related disorders 55 103175 103175 Multiple Sclerosis, Covid-19, Vaccine, Vaccination, Uk Ms Register 1 10 2021 2021-10-01 10.1016/j.msard.2021.103175 COLLEGE NANME Health Data Science COLLEGE CODE HDAT Swansea University Multiple Sclerosis Society Grant: 001 2021-10-20T17:55:23.5473527 2021-09-07T11:41:43.5583416 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Yun Huang 1 Jeff Rodgers 2 Rod Middleton 0000-0002-2130-4420 3 Aravindhan Baheerathan 4 Katherine Tuite-Dalton 5 David Ford 0000-0001-6551-721X 6 Richard Nicholas 7 Ms Register Research Group 8 57795__20766__fc093eb8d3144f568f79301bd6f68919.pdf 57795.pdf 2021-09-07T12:25:21.2458924 Output 322695 application/pdf Accepted Manuscript true 2022-07-27T00:00:00.0000000 ©2021 All rights reserved. All article content, except where otherwise noted, is licensed under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND) true eng https://creativecommons.org/licenses/by-nc-nd/4.0/
title Willingness to receive a COVID-19 vaccine in people with multiple sclerosis - UK MS Register survey
spellingShingle Willingness to receive a COVID-19 vaccine in people with multiple sclerosis - UK MS Register survey
Jeff Rodgers
Rod Middleton
Katherine Tuite-Dalton
David Ford
title_short Willingness to receive a COVID-19 vaccine in people with multiple sclerosis - UK MS Register survey
title_full Willingness to receive a COVID-19 vaccine in people with multiple sclerosis - UK MS Register survey
title_fullStr Willingness to receive a COVID-19 vaccine in people with multiple sclerosis - UK MS Register survey
title_full_unstemmed Willingness to receive a COVID-19 vaccine in people with multiple sclerosis - UK MS Register survey
title_sort Willingness to receive a COVID-19 vaccine in people with multiple sclerosis - UK MS Register survey
author_id_str_mv 3ee27bde2acae56844ecdcbb563218ac
005518f819ef1a2a13fdf438529bdfcd
2e25da269f03da81184357bb0ef8623d
52fc0c473b0da1b7218d87f9fc68a3e6
author_id_fullname_str_mv 3ee27bde2acae56844ecdcbb563218ac_***_Jeff Rodgers
005518f819ef1a2a13fdf438529bdfcd_***_Rod Middleton
2e25da269f03da81184357bb0ef8623d_***_Katherine Tuite-Dalton
52fc0c473b0da1b7218d87f9fc68a3e6_***_David Ford
author Jeff Rodgers
Rod Middleton
Katherine Tuite-Dalton
David Ford
author2 Yun Huang
Jeff Rodgers
Rod Middleton
Aravindhan Baheerathan
Katherine Tuite-Dalton
David Ford
Richard Nicholas
Ms Register Research Group
format Journal article
container_title Multiple sclerosis and related disorders
container_volume 55
container_start_page 103175
publishDate 2021
institution Swansea University
doi_str_mv 10.1016/j.msard.2021.103175
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
description Background & Methods: We conducted an online COVID-19 survey as the vaccines became available, utilising the UK MS Register, to understand people with multiple sclerosis (pwMS) views on COVID-19 vaccination and the subsequent vaccine uptake rates.Results & Conclusion: 94.4% of 3191 pwMS surveyed indicated they would get a COVID-19 vaccine, while 5.6% would not. PwMS who have previously had an influenza vaccine, increasing age and the perception of having sufficient information about the vaccine were associated with increased likelihood of getting a vaccine. 51.7% of 3191 pwMS completed a follow-up survey indicating they received at least 1 dose of a COVID-19 vaccine. The proportion having had the vaccination based on their prior opinions was 53.2% in ‘Yes’ group and 27.0% in ‘No’ group, the latter reflecting a change based on their initial views. More information on COVID-19 vaccine safety in pwMS would be helpful for people to make informed decisions.
published_date 2021-10-01T04:13:48Z
_version_ 1763753935196127232
score 11.012924

Similar Items